Lab Notes: Larimar plans $70M stock sale, gets FDA clearance to resume clinical testing
September 16, 2022 at 11:35 AM EDT
A Villanova-based biotech startup focus on heart disease gets a new CEO
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Events | Directory | Real Estate | Blog | More
|